– UK, London – LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today announced the appointment of Todd Schermerhorn to its Board of Directors, effective December 3.
“Todd is a highly respected leader within the medical technology and healthcare fields. His deep financial knowledge specific to medical devices will enable him to be an immediate contributor and will enrich our Board,” said Dr. Sharon O’Kane, Nominating and Corporate Governance Committee Chair. “On behalf of the Board, I welcome Todd and look forward to him sharing his insight, expertise and financial acumen in his capacity as Audit and Compliance Committee Chair.”
The company also announced that Hugh Morrison has decided not to stand for re-election at the LivaNova 2021 Annual General Meeting of Shareholders.
Daniel Moore, Board Chair said, “I feel very honored to have worked so closely with Hugh for the last five years as we have seen LivaNova grow into the medical device leader that it is today. The guidance, counsel, and dedication that Hugh brought to the Board and our team at LivaNova was unparalleled. We all wish Hugh the best as he moves on to his next endeavor.”
The Company also announced that Daniel Moore will rotate from the role of Board Chair, effective as of the 2021 AGM. Moore will remain a Director. William Kozy, who currently serves on the Nominating and Corporate Governance Committee, will succeed Moore as Chair at that time.
Kozy joined the LivaNova Board in 2018 and also serves on the Board of Cooper Companies, Inc. He previously served as Executive VP and COO of Becton, Dickinson and Company, a global medical technology company, until his retirement in 2016.
About Todd Schermerhorn
Schermerhorn has 35 years of experience in global healthcare, including 27 years at C.R. Bard Inc. where he held various positions of increasing responsibility on the finance team, which culminated with his nine-year tenure as Chief Financial Officer. He was a Director of Thoratec Corporation and The Spectranetics Corporation and currently serves on the Boards of Metabolon Inc. and The Travelers Companies Inc., where he is the Independent Lead Director and chairs its Risk Committee.
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. LivaNova’s advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems. Headquartered in London, LivaNova has a presence in more than 100 countries worldwide.
For more information: https://www.livanova.com/en-US/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.